Ken Griffin acquired 13 XBiotech shares worth $36. That's 0.00% of their equity portfolio (4683rd largest holding). The first XBiotech trade was made in Q1 2017. Since then Ken Griffin bought shares 28 more times and sold shares on 28 occasions. The investor's estimated purchase price is $87.7, resulting in a loss of 59%.